Treating acute promyelocytic leukaemia in Latin America: lessons from the International Consortium on Acute Leukaemia experience

被引:9
|
作者
de Araujo Koury, Luisa Correa [1 ,2 ]
Ganser, Arnold [3 ]
Berliner, Nancy [4 ]
Rego, Eduardo M. [1 ,2 ]
机构
[1] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, Av Bandeirantes 3900, BR-14048900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Ctr Cell Based Therapy, Ribeirao Preto, SP, Brazil
[3] Hannover Med Sch, Dept Haematol Haemostasis Oncol & Stem Cell Trans, Hannover, Germany
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA
关键词
acute promyelocytic leukaemia; leukaemia therapy; clinical network; developing world; TRANS-RETINOIC ACID; RISK-ADAPTED TREATMENT; ARSENIC TRIOXIDE; HEALTH; CONSOLIDATION; INEQUALITIES; ANTHRACYCLINE; COUNTRIES; ANTIBODY; PETHEMA;
D O I
10.1111/bjh.14589
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Latin Americas and Caribbean are regions where social exclusion and inequality persist as the main obstacles to human development and improvement of health conditions, despite economic growth and social development. These countries need to establish international collaborations with the goal of improving health conditions. In this scenario Acute Promyelocytic Leukaemia (APL), a disease with a high cure rate in developed countries and high prevalence in young patients, offers an ideal opportunity to implement measures with educational and cooperative scope. We discuss the experience of Latin America and the Caribbean through a common network, the International Consortium on Acute Promyelocytic Leukaemia (IC-APL).
引用
收藏
页码:979 / 983
页数:5
相关论文
共 50 条
  • [1] Differentiation syndrome in acute promyelocytic leukaemia
    Stahl, Maximilian
    Tallman, Martin S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) : 157 - 162
  • [2] The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia
    Lange, Ana P.
    Lima, Ana S.
    Lucena-Araujo, Antonio R.
    Jacomo, Rafael H.
    Melo, Raul A.
    Bittencourt, Rosane I.
    Pasquini, Ricardo
    Pagnano, Katia
    Fagundes, Evandro M.
    Chauffaille, Maria L.
    Chiattone, Carlos S.
    Sanz, Miguel A.
    Lo-Coco, Francesco
    Grimwade, David
    Rego, Eduardo M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (06) : 915 - 918
  • [3] The history of acute promyelocytic leukaemia
    Degos, L
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (04) : 539 - 553
  • [4] The coagulopathy of acute promyelocytic leukaemia revisited
    Stein, Eytan
    McMahon, Brandon
    Kwaan, Hau
    Altman, Jessica K.
    Frankfurt, Olga
    Tallman, Martin S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (01) : 153 - 163
  • [5] Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia
    Luesink, Maaike
    Jansen, Joop H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (03) : 209 - 220
  • [6] Current standard treatment of adult acute promyelocytic leukaemia
    Lo-Coco, Francesco
    Cicconi, Laura
    Breccia, Massimo
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (06) : 841 - 854
  • [7] The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia
    Breen, Karen A.
    Grimwade, David
    Hunt, Beverley J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (01) : 24 - 36
  • [8] Acute promyelocytic leukaemia: a review
    Parmar, S
    Tallman, MS
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (08) : 1379 - 1392
  • [9] Acute promyelocytic leukaemia in children
    Gregory, J
    Feusner, J
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (03) : 483 - 494
  • [10] The epidemiology of acute promyelocytic leukaemia
    Douer, D
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (03) : 357 - 367